The role of young children in a community-wide outbreak of hepatitis A

Epidemiology and Infection

Volumn 118, Issue 3, 1997, Pages 243-252

  Smith, P F ^a,b,e   Grabau, J C ^a   Werzberger, A ^c   Gunn, R A ^d   Rolka, H R ^d   Kondracki, S F ^a   Gallo, R J ^a   Morse, D L ^a,b  

^a NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e ESP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE;

ARTICLE; COMMUNITY; FAMILY; HEPATITIS A; HEPATITIS A VIRUS; HOUSEHOLD; HUMAN; INFECTION CONTROL; JEW; PRESCHOOL CHILD; RISK FACTOR; SEROLOGY; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HEPATITIS A; HUMANS; INFANT; JEWS; MALE; NEW YORK; PREVALENCE; RETROSPECTIVE STUDIES; RISK; RISK FACTORS;

EID: 0030748054     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268897007462     Document Type: Article

References (38)

1. Centers for Disease Control and Prevention. Summary of notifiable diseases, United States, 1994. MMWR 1994; 43 (53): 3.
2. Gust ID. Epidemiological patterns of hepatitis A in different parts of the world. Vaccine 1992; 10(Suppl 1): S56-8.
3. Siegl G, Lemon SM. Recent advances in hepatitis A vaccine development. Virus Res 1990; 17: 75-92.
4. Lemon SM. Type A viral hepatitis. New developments in an old disease. N Engl J Med 1985; 313: 1059-67.
5. Shapiro CN, Coleman PJ, McQuillan GM, Alter MJ, Margolis HS. Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA. Vaccine 1992; 10(Suppl 1): S59-62.
6. Shaw FE, Sudman JH, Smith SM, et al. A communitywide epidemic of hepatitis A in Ohio. Am J Epidemiol 1986; 123: 1057-65.
7. Shaw FE, Shapiro CN, Welty TK, Dill W, Reddington J, Hadler SC. Hepatitis transmission among the Sioux Indians of South Dakota. Am J Public Health 1990; 80: 1091-4.
8. Majeed FA, Stuart JM, Cartwright KAV, et al. An outbreak of hepatitis A in Gloucester, UK. Epidemiol Infect 1992; 109: 167-73.
9. Pavia AT, Nielsen L, Armington L, Thurman DJ, Tiernay E, Nichols CR. A community-wide outbreak of hepatitis A in a religious community : impact of mass administration of immune globulin. Am J Epidemiol 1990; 131: 1085-93.
10. Werzberger A, Mensch B, Kuter B, et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med 1992; 327: 453-7.
11. Margolis HS, Shapiro CN. Who should receive hepatitis A vaccine? Considerations for the development of an immunization strategy. Vaccine 1992; 10 (Suppl 1): S85-7.
12. Dean AG, Dean JA, Burton AH, Dicker RC. Epi Info, Version 5: a word processing, database, and statistics program for epidemiology on microcomputers. USD, Incorporated, Stone Mountain, Georgia, 1990.
13. Gebski V, Leung O, McNeil D, Lunn D. SPIDA Version 6.0. Statistical Computing Laboratory Pty. Ltd., Australia, 1992.
14. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley and Sons, 1989: 129-31.
15. Ispen J, Donovan WR, James G. Sociologic factors in the spread of epidemic hepatitis in a rural school district. J Hyg 1952; 50: 457-70.
16. Lilienfeld AM, Bross IDJ, Sartwell PE. Observations of an outbreak of infectious hepatitis in Baltimore during 1951. Am J Public Health 1953; 43: 1085-96.
17. Barondess JA, Drake ME, Bashe WJ, et al. Epidemic of infectious hepatitis. Some notes on delineation of high-risk groups and protection of exposed susceptibles by gamma globulin. Arch Intern Med 1995; 95: 633-45.
18. Mosley WH, Speers JF, Chin TDY. Epidemiologic studies of a large urban outbreak of infectious hepatitis. Am J Public Health 1963; 53: 1603-17.
19. Crusberg TC, Burke WM, Reynolds JT, Morse LE, Reilly J, Hoffmann AH. The reappearance of a classical epidemic of infectious hepatitis in Worcester, Massachusetts. Am J Epidemiol 1978; 107: 545-51.
20. Desenclose JA, MacLafferty L. Community wide outbreak of hepatitis A linked to children in day care centres and with increased transmission in young adult men in Florida 1988-9. J Epidemiol Commun Health 1993; 47: 269-73.
21. Ashley A. Gamma globulin. Effect on secondary attack rates in infectious hepatitis. N Engl J Med 1954; 250: 412-7.
22. Maguire HC, Handford S, Perry KR, et al. A collaborative case control study of sporadic hepatitis A in England. Commun Dis Rep Rev 1995; 5: R33-40.
23. Hadler SC, Webster HM, Erben JJ, Swanson JE, Maynard JE. Hepatitis A in day-care centers. A community-wide assessment. N Engl J Med 1980; 302: 1222-7.
24. Hadler SC, Erben JJ, Francis DP, Webster HM, Maynard JE. Risk factors for hepatitis A in day-care centers. J Infect Dis 1982; 145: 255-61.
25. Storch G, McFarland LM, Kelso K, Heilman CJ, Caraway CT. Viral hepatitis associated with day-care centers. JAMA 1979; 242: 1514-8.
26. Klein BS, Michaels JA, Rytel MW, Berg KG, Davis JP. Nosocomial hepatitis A. A multinursery outbreak in Wisconsin. JAMA 1984; 252: 2716-21.
27. Hoff RS, Galambos J. Viral hepatitis. In: Schiff L, Schiff ER, eds. Diseases of the liver. 5th edn. Philadelphia: JB Lippincott, 1982: 498-9.
28. Green MS, Zaaide Y. Sibship size as a risk factor for hepatitis A infection. Am J Epidemiol 1989; 129: 800-5.
29. Frosner GG, Papaevangelou G, Butler R, et al. Antibody against hepatitis A in seven European countries. I. Comparison of prevalence data in different age groups. Am J Epidemiol 1979; 110: 63-9.
30. Szmuness W, Dienstag JL, Purcell RH, et al. The prevalence of antibody to hepatitis A antigen in various parts of the world : A pilot study. Am J Epidemiol 1977 ; 106: 392-8.
31. Szmuness W, Dienstag JL, Purcell RH, Harley EJ, Stevens CE, Wong DC. Distribution of antibody to hepatitis A antigen in urban adult populations. N Engl J Med 1976; 295: 755-9.
32. Landrigan PJ, Huber DH, Murphy GD, Creech WB, Bryan JA. The protective efficacy of immune serum globulin in hepatitis A. A statistical approach. JAMA 1973; 223: 74-5.
33. Hall WT, Madden DL, Mundon FK, Brandt DEL, Clarke NA. Protective effect of immune serum globulin (ISG) against hepatitis A infection in a natural epidemic. Am J Epidemiol 1977; 106: 72-5.
34. Gellis SS, Stokes J, Brother GM, et al. The use of human immune serum globulin (gamma globulin) in infectious (epidemic) hepatitis in the Mediterranean theater of operations. I. Studies on propylaxis in two epidemics of infectious hepatitis. JAMA 1945; 128: 1062-3.
35. Krugman S, Ward R, Giles JP, Jacobs AM. Infectious hepatitis. Studies on the effect of gamma globulin and on the incidence of inapparent infection. JAMA 1960; 174: 823-30.
36. Hadler SC, Erben JJ, Matthews D, Starko K, Francis DP, Maynard JE. Effect of immunoglobulin on hepatitis A in day-care centers. JAMA 1983; 249: 48-53.
37. Purcell RH, D'Hondt E, Bradbury R, Emerson SU, Govindarajan S, Binn L. Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees. Vaccine 1992; 10 (Suppl 1): S148-51.
38. McMahon BJ, Beller M, Williams J, et al. A program to control an outbreak of hepatitis A in Alaska using an inactivated hepatitis A vaccine. Presented at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Florida, October 1994.